| Meditelecare Of Iowa Pllc | |
|
400 E Court Ave Ste 110 Des Moines IA 50309-2027 | |
| (860) 788-6404 | |
| (860) 829-0495 |
| Full Name | Meditelecare Of Iowa Pllc |
|---|---|
| Speciality | Psychologist |
| Location | 400 E Court Ave Ste 110, Des Moines, Iowa |
| Authorized Official Name and Position | Andrea Godfrey (CREDENTIALING & ENROLLMENT MANAGER) |
| Authorized Official Contact | 8607886404 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Meditelecare Of Iowa Pllc Po Box 1595 Middletown CT 06457-8095 Ph: (860) 788-6404 | Meditelecare Of Iowa Pllc 400 E Court Ave Ste 110 Des Moines IA 50309-2027 Ph: (860) 788-6404 |
| NPI Number | 1386146678 |
|---|---|
| Provider Enumeration Date | 03/02/2018 |
| Last Update Date | 05/06/2024 |
| Certification Date | 05/06/2024 |
| Medicare PECOS PAC ID | 0446512503 |
|---|---|
| Medicare Enrollment ID | O20180329001998 |
News Archive
New research could lead to a better understanding of how the brain works in people with autism.
An international team led by Munich-based researchers has found a genetic score that reliably predicts the risk, severity and age of onset of depression in young people. The study also confirms a history of childhood abuse as a risk factor.
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, such as high cholesterol or high blood pressure, according to a new study published online in the journal Radiology.
Sunesis Pharmaceuticals, Inc. has announced a presentation of updated interim results from an ongoing Phase 2 clinical trial demonstrating that the Company's lead product candidate, voreloxin, shows promising efficacy and safety as a single agent in patients with platinum-resistant ovarian cancer.
Researchers from the University of Georgia have determined that various freshwater sources in Georgia, such as rivers and lakes, could feature levels of salmonella that pose a risk to humans.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386146678 | NPI | - | NPPES |
| Provider Name | Laura J Dunlap |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1184666000 PECOS PAC ID: 3971576356 Enrollment ID: I20050728001104 |
News Archive
New research could lead to a better understanding of how the brain works in people with autism.
An international team led by Munich-based researchers has found a genetic score that reliably predicts the risk, severity and age of onset of depression in young people. The study also confirms a history of childhood abuse as a risk factor.
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, such as high cholesterol or high blood pressure, according to a new study published online in the journal Radiology.
Sunesis Pharmaceuticals, Inc. has announced a presentation of updated interim results from an ongoing Phase 2 clinical trial demonstrating that the Company's lead product candidate, voreloxin, shows promising efficacy and safety as a single agent in patients with platinum-resistant ovarian cancer.
Researchers from the University of Georgia have determined that various freshwater sources in Georgia, such as rivers and lakes, could feature levels of salmonella that pose a risk to humans.
› Verified 7 days ago
| Provider Name | Ana Mercedes Lopez |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1790993962 PECOS PAC ID: 5597788117 Enrollment ID: I20060110000713 |
News Archive
New research could lead to a better understanding of how the brain works in people with autism.
An international team led by Munich-based researchers has found a genetic score that reliably predicts the risk, severity and age of onset of depression in young people. The study also confirms a history of childhood abuse as a risk factor.
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, such as high cholesterol or high blood pressure, according to a new study published online in the journal Radiology.
Sunesis Pharmaceuticals, Inc. has announced a presentation of updated interim results from an ongoing Phase 2 clinical trial demonstrating that the Company's lead product candidate, voreloxin, shows promising efficacy and safety as a single agent in patients with platinum-resistant ovarian cancer.
Researchers from the University of Georgia have determined that various freshwater sources in Georgia, such as rivers and lakes, could feature levels of salmonella that pose a risk to humans.
› Verified 7 days ago
| Provider Name | Cheryl Lynn White |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1164414561 PECOS PAC ID: 7214995216 Enrollment ID: I20160812001526 |
News Archive
New research could lead to a better understanding of how the brain works in people with autism.
An international team led by Munich-based researchers has found a genetic score that reliably predicts the risk, severity and age of onset of depression in young people. The study also confirms a history of childhood abuse as a risk factor.
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, such as high cholesterol or high blood pressure, according to a new study published online in the journal Radiology.
Sunesis Pharmaceuticals, Inc. has announced a presentation of updated interim results from an ongoing Phase 2 clinical trial demonstrating that the Company's lead product candidate, voreloxin, shows promising efficacy and safety as a single agent in patients with platinum-resistant ovarian cancer.
Researchers from the University of Georgia have determined that various freshwater sources in Georgia, such as rivers and lakes, could feature levels of salmonella that pose a risk to humans.
› Verified 7 days ago
| Provider Name | Joanie Defibaugh |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1417011313 PECOS PAC ID: 5698814846 Enrollment ID: I20160912000826 |
News Archive
New research could lead to a better understanding of how the brain works in people with autism.
An international team led by Munich-based researchers has found a genetic score that reliably predicts the risk, severity and age of onset of depression in young people. The study also confirms a history of childhood abuse as a risk factor.
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, such as high cholesterol or high blood pressure, according to a new study published online in the journal Radiology.
Sunesis Pharmaceuticals, Inc. has announced a presentation of updated interim results from an ongoing Phase 2 clinical trial demonstrating that the Company's lead product candidate, voreloxin, shows promising efficacy and safety as a single agent in patients with platinum-resistant ovarian cancer.
Researchers from the University of Georgia have determined that various freshwater sources in Georgia, such as rivers and lakes, could feature levels of salmonella that pose a risk to humans.
› Verified 7 days ago
| Provider Name | Misty Boyd |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1568455764 PECOS PAC ID: 8729000344 Enrollment ID: I20170405002358 |
News Archive
New research could lead to a better understanding of how the brain works in people with autism.
An international team led by Munich-based researchers has found a genetic score that reliably predicts the risk, severity and age of onset of depression in young people. The study also confirms a history of childhood abuse as a risk factor.
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, such as high cholesterol or high blood pressure, according to a new study published online in the journal Radiology.
Sunesis Pharmaceuticals, Inc. has announced a presentation of updated interim results from an ongoing Phase 2 clinical trial demonstrating that the Company's lead product candidate, voreloxin, shows promising efficacy and safety as a single agent in patients with platinum-resistant ovarian cancer.
Researchers from the University of Georgia have determined that various freshwater sources in Georgia, such as rivers and lakes, could feature levels of salmonella that pose a risk to humans.
› Verified 7 days ago
| Provider Name | Amarachi Chika Ogbonnaya-akpa |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1386038024 PECOS PAC ID: 9436461266 Enrollment ID: I20170629002382 |
News Archive
New research could lead to a better understanding of how the brain works in people with autism.
An international team led by Munich-based researchers has found a genetic score that reliably predicts the risk, severity and age of onset of depression in young people. The study also confirms a history of childhood abuse as a risk factor.
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, such as high cholesterol or high blood pressure, according to a new study published online in the journal Radiology.
Sunesis Pharmaceuticals, Inc. has announced a presentation of updated interim results from an ongoing Phase 2 clinical trial demonstrating that the Company's lead product candidate, voreloxin, shows promising efficacy and safety as a single agent in patients with platinum-resistant ovarian cancer.
Researchers from the University of Georgia have determined that various freshwater sources in Georgia, such as rivers and lakes, could feature levels of salmonella that pose a risk to humans.
› Verified 7 days ago
| Provider Name | Vickie L Robbins |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1417046962 PECOS PAC ID: 7517289788 Enrollment ID: I20180405001851 |
News Archive
New research could lead to a better understanding of how the brain works in people with autism.
An international team led by Munich-based researchers has found a genetic score that reliably predicts the risk, severity and age of onset of depression in young people. The study also confirms a history of childhood abuse as a risk factor.
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, such as high cholesterol or high blood pressure, according to a new study published online in the journal Radiology.
Sunesis Pharmaceuticals, Inc. has announced a presentation of updated interim results from an ongoing Phase 2 clinical trial demonstrating that the Company's lead product candidate, voreloxin, shows promising efficacy and safety as a single agent in patients with platinum-resistant ovarian cancer.
Researchers from the University of Georgia have determined that various freshwater sources in Georgia, such as rivers and lakes, could feature levels of salmonella that pose a risk to humans.
› Verified 7 days ago
| Provider Name | Sharon B Stegall |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1447580816 PECOS PAC ID: 9133255300 Enrollment ID: I20180507000191 |
News Archive
New research could lead to a better understanding of how the brain works in people with autism.
An international team led by Munich-based researchers has found a genetic score that reliably predicts the risk, severity and age of onset of depression in young people. The study also confirms a history of childhood abuse as a risk factor.
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, such as high cholesterol or high blood pressure, according to a new study published online in the journal Radiology.
Sunesis Pharmaceuticals, Inc. has announced a presentation of updated interim results from an ongoing Phase 2 clinical trial demonstrating that the Company's lead product candidate, voreloxin, shows promising efficacy and safety as a single agent in patients with platinum-resistant ovarian cancer.
Researchers from the University of Georgia have determined that various freshwater sources in Georgia, such as rivers and lakes, could feature levels of salmonella that pose a risk to humans.
› Verified 7 days ago
| Provider Name | Holly E Labertew |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1023517125 PECOS PAC ID: 6103180625 Enrollment ID: I20180510000261 |
News Archive
New research could lead to a better understanding of how the brain works in people with autism.
An international team led by Munich-based researchers has found a genetic score that reliably predicts the risk, severity and age of onset of depression in young people. The study also confirms a history of childhood abuse as a risk factor.
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, such as high cholesterol or high blood pressure, according to a new study published online in the journal Radiology.
Sunesis Pharmaceuticals, Inc. has announced a presentation of updated interim results from an ongoing Phase 2 clinical trial demonstrating that the Company's lead product candidate, voreloxin, shows promising efficacy and safety as a single agent in patients with platinum-resistant ovarian cancer.
Researchers from the University of Georgia have determined that various freshwater sources in Georgia, such as rivers and lakes, could feature levels of salmonella that pose a risk to humans.
› Verified 7 days ago
| Provider Name | Cheryl A France |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1134144215 PECOS PAC ID: 1557550175 Enrollment ID: I20181012002667 |
News Archive
New research could lead to a better understanding of how the brain works in people with autism.
An international team led by Munich-based researchers has found a genetic score that reliably predicts the risk, severity and age of onset of depression in young people. The study also confirms a history of childhood abuse as a risk factor.
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, such as high cholesterol or high blood pressure, according to a new study published online in the journal Radiology.
Sunesis Pharmaceuticals, Inc. has announced a presentation of updated interim results from an ongoing Phase 2 clinical trial demonstrating that the Company's lead product candidate, voreloxin, shows promising efficacy and safety as a single agent in patients with platinum-resistant ovarian cancer.
Researchers from the University of Georgia have determined that various freshwater sources in Georgia, such as rivers and lakes, could feature levels of salmonella that pose a risk to humans.
› Verified 7 days ago
| Provider Name | Tiffany Nickie-hull |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1457503534 PECOS PAC ID: 7719268374 Enrollment ID: I20181017000140 |
News Archive
New research could lead to a better understanding of how the brain works in people with autism.
An international team led by Munich-based researchers has found a genetic score that reliably predicts the risk, severity and age of onset of depression in young people. The study also confirms a history of childhood abuse as a risk factor.
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, such as high cholesterol or high blood pressure, according to a new study published online in the journal Radiology.
Sunesis Pharmaceuticals, Inc. has announced a presentation of updated interim results from an ongoing Phase 2 clinical trial demonstrating that the Company's lead product candidate, voreloxin, shows promising efficacy and safety as a single agent in patients with platinum-resistant ovarian cancer.
Researchers from the University of Georgia have determined that various freshwater sources in Georgia, such as rivers and lakes, could feature levels of salmonella that pose a risk to humans.
› Verified 7 days ago
| Provider Name | Sylvia K Williams |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1437485323 PECOS PAC ID: 5193869360 Enrollment ID: I20181203000549 |
News Archive
New research could lead to a better understanding of how the brain works in people with autism.
An international team led by Munich-based researchers has found a genetic score that reliably predicts the risk, severity and age of onset of depression in young people. The study also confirms a history of childhood abuse as a risk factor.
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, such as high cholesterol or high blood pressure, according to a new study published online in the journal Radiology.
Sunesis Pharmaceuticals, Inc. has announced a presentation of updated interim results from an ongoing Phase 2 clinical trial demonstrating that the Company's lead product candidate, voreloxin, shows promising efficacy and safety as a single agent in patients with platinum-resistant ovarian cancer.
Researchers from the University of Georgia have determined that various freshwater sources in Georgia, such as rivers and lakes, could feature levels of salmonella that pose a risk to humans.
› Verified 7 days ago
| Provider Name | Regina Young |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1124298849 PECOS PAC ID: 5193895845 Enrollment ID: I20190301000760 |
News Archive
New research could lead to a better understanding of how the brain works in people with autism.
An international team led by Munich-based researchers has found a genetic score that reliably predicts the risk, severity and age of onset of depression in young people. The study also confirms a history of childhood abuse as a risk factor.
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, such as high cholesterol or high blood pressure, according to a new study published online in the journal Radiology.
Sunesis Pharmaceuticals, Inc. has announced a presentation of updated interim results from an ongoing Phase 2 clinical trial demonstrating that the Company's lead product candidate, voreloxin, shows promising efficacy and safety as a single agent in patients with platinum-resistant ovarian cancer.
Researchers from the University of Georgia have determined that various freshwater sources in Georgia, such as rivers and lakes, could feature levels of salmonella that pose a risk to humans.
› Verified 7 days ago
| Provider Name | Kimberly Souza |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1902200645 PECOS PAC ID: 3072735703 Enrollment ID: I20190410003123 |
News Archive
New research could lead to a better understanding of how the brain works in people with autism.
An international team led by Munich-based researchers has found a genetic score that reliably predicts the risk, severity and age of onset of depression in young people. The study also confirms a history of childhood abuse as a risk factor.
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, such as high cholesterol or high blood pressure, according to a new study published online in the journal Radiology.
Sunesis Pharmaceuticals, Inc. has announced a presentation of updated interim results from an ongoing Phase 2 clinical trial demonstrating that the Company's lead product candidate, voreloxin, shows promising efficacy and safety as a single agent in patients with platinum-resistant ovarian cancer.
Researchers from the University of Georgia have determined that various freshwater sources in Georgia, such as rivers and lakes, could feature levels of salmonella that pose a risk to humans.
› Verified 7 days ago
| Provider Name | Katrina Alexander |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1821498312 PECOS PAC ID: 6204260656 Enrollment ID: I20191218001712 |
News Archive
New research could lead to a better understanding of how the brain works in people with autism.
An international team led by Munich-based researchers has found a genetic score that reliably predicts the risk, severity and age of onset of depression in young people. The study also confirms a history of childhood abuse as a risk factor.
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, such as high cholesterol or high blood pressure, according to a new study published online in the journal Radiology.
Sunesis Pharmaceuticals, Inc. has announced a presentation of updated interim results from an ongoing Phase 2 clinical trial demonstrating that the Company's lead product candidate, voreloxin, shows promising efficacy and safety as a single agent in patients with platinum-resistant ovarian cancer.
Researchers from the University of Georgia have determined that various freshwater sources in Georgia, such as rivers and lakes, could feature levels of salmonella that pose a risk to humans.
› Verified 7 days ago
| Provider Name | Kathleen Tallent |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1528238698 PECOS PAC ID: 5991874455 Enrollment ID: I20200419000301 |
News Archive
New research could lead to a better understanding of how the brain works in people with autism.
An international team led by Munich-based researchers has found a genetic score that reliably predicts the risk, severity and age of onset of depression in young people. The study also confirms a history of childhood abuse as a risk factor.
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, such as high cholesterol or high blood pressure, according to a new study published online in the journal Radiology.
Sunesis Pharmaceuticals, Inc. has announced a presentation of updated interim results from an ongoing Phase 2 clinical trial demonstrating that the Company's lead product candidate, voreloxin, shows promising efficacy and safety as a single agent in patients with platinum-resistant ovarian cancer.
Researchers from the University of Georgia have determined that various freshwater sources in Georgia, such as rivers and lakes, could feature levels of salmonella that pose a risk to humans.
› Verified 7 days ago
| Provider Name | Marie Bissell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1922393776 PECOS PAC ID: 2668650011 Enrollment ID: I20200515001409 |
News Archive
New research could lead to a better understanding of how the brain works in people with autism.
An international team led by Munich-based researchers has found a genetic score that reliably predicts the risk, severity and age of onset of depression in young people. The study also confirms a history of childhood abuse as a risk factor.
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, such as high cholesterol or high blood pressure, according to a new study published online in the journal Radiology.
Sunesis Pharmaceuticals, Inc. has announced a presentation of updated interim results from an ongoing Phase 2 clinical trial demonstrating that the Company's lead product candidate, voreloxin, shows promising efficacy and safety as a single agent in patients with platinum-resistant ovarian cancer.
Researchers from the University of Georgia have determined that various freshwater sources in Georgia, such as rivers and lakes, could feature levels of salmonella that pose a risk to humans.
› Verified 7 days ago
| Provider Name | Michelle Sarah Paradise |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1538375324 PECOS PAC ID: 3870871742 Enrollment ID: I20201207002757 |
News Archive
New research could lead to a better understanding of how the brain works in people with autism.
An international team led by Munich-based researchers has found a genetic score that reliably predicts the risk, severity and age of onset of depression in young people. The study also confirms a history of childhood abuse as a risk factor.
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, such as high cholesterol or high blood pressure, according to a new study published online in the journal Radiology.
Sunesis Pharmaceuticals, Inc. has announced a presentation of updated interim results from an ongoing Phase 2 clinical trial demonstrating that the Company's lead product candidate, voreloxin, shows promising efficacy and safety as a single agent in patients with platinum-resistant ovarian cancer.
Researchers from the University of Georgia have determined that various freshwater sources in Georgia, such as rivers and lakes, could feature levels of salmonella that pose a risk to humans.
› Verified 7 days ago
| Provider Name | Gabrielle Frankenfield |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1811231749 PECOS PAC ID: 4486806726 Enrollment ID: I20210802001916 |
News Archive
New research could lead to a better understanding of how the brain works in people with autism.
An international team led by Munich-based researchers has found a genetic score that reliably predicts the risk, severity and age of onset of depression in young people. The study also confirms a history of childhood abuse as a risk factor.
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, such as high cholesterol or high blood pressure, according to a new study published online in the journal Radiology.
Sunesis Pharmaceuticals, Inc. has announced a presentation of updated interim results from an ongoing Phase 2 clinical trial demonstrating that the Company's lead product candidate, voreloxin, shows promising efficacy and safety as a single agent in patients with platinum-resistant ovarian cancer.
Researchers from the University of Georgia have determined that various freshwater sources in Georgia, such as rivers and lakes, could feature levels of salmonella that pose a risk to humans.
› Verified 7 days ago
| Provider Name | Salvi M Alday |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1871239954 PECOS PAC ID: 2961884721 Enrollment ID: I20220727000665 |
News Archive
New research could lead to a better understanding of how the brain works in people with autism.
An international team led by Munich-based researchers has found a genetic score that reliably predicts the risk, severity and age of onset of depression in young people. The study also confirms a history of childhood abuse as a risk factor.
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, such as high cholesterol or high blood pressure, according to a new study published online in the journal Radiology.
Sunesis Pharmaceuticals, Inc. has announced a presentation of updated interim results from an ongoing Phase 2 clinical trial demonstrating that the Company's lead product candidate, voreloxin, shows promising efficacy and safety as a single agent in patients with platinum-resistant ovarian cancer.
Researchers from the University of Georgia have determined that various freshwater sources in Georgia, such as rivers and lakes, could feature levels of salmonella that pose a risk to humans.
› Verified 7 days ago
| Provider Name | Emily Drury |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1659889319 PECOS PAC ID: 5991041295 Enrollment ID: I20221026001914 |
News Archive
New research could lead to a better understanding of how the brain works in people with autism.
An international team led by Munich-based researchers has found a genetic score that reliably predicts the risk, severity and age of onset of depression in young people. The study also confirms a history of childhood abuse as a risk factor.
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, such as high cholesterol or high blood pressure, according to a new study published online in the journal Radiology.
Sunesis Pharmaceuticals, Inc. has announced a presentation of updated interim results from an ongoing Phase 2 clinical trial demonstrating that the Company's lead product candidate, voreloxin, shows promising efficacy and safety as a single agent in patients with platinum-resistant ovarian cancer.
Researchers from the University of Georgia have determined that various freshwater sources in Georgia, such as rivers and lakes, could feature levels of salmonella that pose a risk to humans.
› Verified 7 days ago
| Provider Name | Cristina Ruzila |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1568727550 PECOS PAC ID: 5799939039 Enrollment ID: I20230125002676 |
News Archive
New research could lead to a better understanding of how the brain works in people with autism.
An international team led by Munich-based researchers has found a genetic score that reliably predicts the risk, severity and age of onset of depression in young people. The study also confirms a history of childhood abuse as a risk factor.
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, such as high cholesterol or high blood pressure, according to a new study published online in the journal Radiology.
Sunesis Pharmaceuticals, Inc. has announced a presentation of updated interim results from an ongoing Phase 2 clinical trial demonstrating that the Company's lead product candidate, voreloxin, shows promising efficacy and safety as a single agent in patients with platinum-resistant ovarian cancer.
Researchers from the University of Georgia have determined that various freshwater sources in Georgia, such as rivers and lakes, could feature levels of salmonella that pose a risk to humans.
› Verified 7 days ago
| Provider Name | Jennifer Glidewell |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1588199970 PECOS PAC ID: 8325428907 Enrollment ID: I20230330001221 |
News Archive
New research could lead to a better understanding of how the brain works in people with autism.
An international team led by Munich-based researchers has found a genetic score that reliably predicts the risk, severity and age of onset of depression in young people. The study also confirms a history of childhood abuse as a risk factor.
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, such as high cholesterol or high blood pressure, according to a new study published online in the journal Radiology.
Sunesis Pharmaceuticals, Inc. has announced a presentation of updated interim results from an ongoing Phase 2 clinical trial demonstrating that the Company's lead product candidate, voreloxin, shows promising efficacy and safety as a single agent in patients with platinum-resistant ovarian cancer.
Researchers from the University of Georgia have determined that various freshwater sources in Georgia, such as rivers and lakes, could feature levels of salmonella that pose a risk to humans.
› Verified 7 days ago
| Provider Name | Jason Walker |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1972026946 PECOS PAC ID: 7719332048 Enrollment ID: I20231028000286 |
News Archive
New research could lead to a better understanding of how the brain works in people with autism.
An international team led by Munich-based researchers has found a genetic score that reliably predicts the risk, severity and age of onset of depression in young people. The study also confirms a history of childhood abuse as a risk factor.
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, such as high cholesterol or high blood pressure, according to a new study published online in the journal Radiology.
Sunesis Pharmaceuticals, Inc. has announced a presentation of updated interim results from an ongoing Phase 2 clinical trial demonstrating that the Company's lead product candidate, voreloxin, shows promising efficacy and safety as a single agent in patients with platinum-resistant ovarian cancer.
Researchers from the University of Georgia have determined that various freshwater sources in Georgia, such as rivers and lakes, could feature levels of salmonella that pose a risk to humans.
› Verified 7 days ago
News Archive
New research could lead to a better understanding of how the brain works in people with autism.
An international team led by Munich-based researchers has found a genetic score that reliably predicts the risk, severity and age of onset of depression in young people. The study also confirms a history of childhood abuse as a risk factor.
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, such as high cholesterol or high blood pressure, according to a new study published online in the journal Radiology.
Sunesis Pharmaceuticals, Inc. has announced a presentation of updated interim results from an ongoing Phase 2 clinical trial demonstrating that the Company's lead product candidate, voreloxin, shows promising efficacy and safety as a single agent in patients with platinum-resistant ovarian cancer.
Researchers from the University of Georgia have determined that various freshwater sources in Georgia, such as rivers and lakes, could feature levels of salmonella that pose a risk to humans.
› Verified 7 days ago
Mercy Ruan Neurology Clinic Central Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1111 6th Ave, East Tower Suite A100, Des Moines, IA 50314 Phone: 515-358-0011 Fax: 515-358-0099 | |
Multicultural Institute Of Therapeutic Excellence Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4313 University Ave, Des Moines, IA 50311 Phone: 515-802-2487 | |
Beyond Wellness Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 699 Walnut St Ste 400, Des Moines, IA 50309 Phone: 855-380-6136 | |
Unitypoint Health - Des Moines Iowa Methodist Medical Center Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 700 E University Ave, Des Moines, IA 50316 Phone: 515-263-5612 | |
The Healing Space Counseling Center, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3810 1/2 Douglas Ave, Des Moines, IA 50310 Phone: 515-423-2333 | |
Openloop Healthcare Partners Pc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 317 6th Ave Ste 400, Des Moines, IA 50309 Phone: 515-216-0962 | |
Child Guidance Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 808 5th Ave, Des Moines, IA 50309 Phone: 515-244-2267 |